Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: J Allergy Clin Immunol. 2017 Dec 19;141(4):1459–1467.e2. doi: 10.1016/j.jaci.2017.09.043

Figure 3.

Figure 3.

Exacerbations and asthma symptom days among four BMI-percentile groups. Box plots (a, b) represent medians and intra-quartile ranges. Whiskers represent 95th% ranges. BMI-percentile grouping did not affect AD or exacerbations among ICS-treated, p>0.05; OW participants treated with placebo demonstrated significantly greater AD and exacerbations compared to NW (p=0.01 for both comparison). P-values in all panels compare BMI-percentiles 10–84 vs. 85–100.